TRAVERE THERAPEUTICS INC's ticker is TVTX and the CUSIP is 89422G107. A total of 156 filers reported holding TRAVERE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 1.15 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $39,293,598 | -55.4% | 4,395,257 | -23.3% | 0.00% | -60.0% |
| Q2 2023 | $88,053,289 | -10.4% | 5,732,636 | +31.2% | 0.01% | -16.7% |
| Q1 2023 | $98,233,554 | -44.7% | 4,367,877 | -48.3% | 0.01% | +20.0% |
| Q4 2022 | $177,662,450 | +111.2% | 8,448,048 | +147.5% | 0.01% | 0.0% |
| Q3 2022 | $84,107,000 | -3.8% | 3,413,415 | -5.4% | 0.01% | 0.0% |
| Q2 2022 | $87,402,000 | +14.6% | 3,607,165 | +21.9% | 0.01% | +25.0% |
| Q1 2022 | $76,263,000 | -14.9% | 2,959,361 | +2.5% | 0.00% | 0.0% |
| Q4 2021 | $89,615,000 | +32.8% | 2,887,077 | +3.8% | 0.00% | 0.0% |
| Q3 2021 | $67,471,000 | +33.9% | 2,782,323 | -19.4% | 0.00% | +33.3% |
| Q2 2021 | $50,392,000 | -17.3% | 3,453,859 | +41.6% | 0.00% | 0.0% |
| Q1 2021 | $60,915,000 | – | 2,439,527 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,084,300 | $15,820,000 | 3.32% |
| ARMISTICE CAPITAL, LLC | 5,748,000 | $83,863,000 | 1.50% |
| RA Capital Management | 5,614,428 | $81,915,000 | 1.32% |
| Krensavage Asset Management, LLC | 140,000 | $2,043,000 | 0.69% |
| CM Management, LLC | 60,000 | $875,000 | 0.63% |
| Altium Capital Management LP | 170,484 | $2,487,000 | 0.58% |
| HighVista Strategies LLC | 53,498 | $781,000 | 0.55% |
| Sio Capital Management, LLC | 150,000 | $2,189,000 | 0.54% |
| MANGROVE PARTNERS IM, LLC | 295,037 | $4,305,000 | 0.44% |
| Rock Springs Capital Management LP | 1,494,164 | $21,800,000 | 0.43% |